|
dopamine norepinephrine reuptake inhibitors |
|
|
|
|
|
endonuclease inhibitors |
|
|
|
enzyme activators |
|
|
|
|
|
|
|
epothilone B analogues |
|
|
|
|
|
estrogen agonists/antagonists |
|
|
|
|
|
extended spectrum penicillins |
|
|
|
Farnesyltransferase inhibitors |
|
|
|
fatty acids |
|
|
|
|
|
|
|
|
|
|
|
|
|
five ht4 agonists |
|
Five Lipoxygenase Inhibitors |
|
|
|
|